Lactoferrin ameliorates non-alcoholic fatty liver disease by modulating hepatic sensitivity to fibroblast growth factor 21

Authors:

Abstract
No abstract available
Funding Information
  • Medical Health Science and Technology Project of Zhejiang Provincial Health Commission (2024KY285)
  • National Natural Science Foundation of China (82574093)
  • National Natural Science Foundation of China (82103812)
  • High-level Innovation and Entrepreneurship Talent Introduction Plan of Jiangsu Province (JSSCBS20211579)
  • Suzhou Medical Health Talents Project (GSWS2021031)
  • National Outstanding Youth Training Program of Children's Hospital Affiliated to Soochow University (YYQ003)